0001567619-22-007442.txt : 20220324 0001567619-22-007442.hdr.sgml : 20220324 20220324171703 ACCESSION NUMBER: 0001567619-22-007442 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220322 FILED AS OF DATE: 20220324 DATE AS OF CHANGE: 20220324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hindson Benjamin J. CENTRAL INDEX KEY: 0001786391 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39035 FILM NUMBER: 22767506 MAIL ADDRESS: STREET 1: 10X GENOMICS, INC. STREET 2: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 10x Genomics, Inc. CENTRAL INDEX KEY: 0001770787 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 455614458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: (925) 401-7300 MAIL ADDRESS: STREET 1: 6230 STONERIDGE MALL ROAD CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: 10X Genomics, Inc. DATE OF NAME CHANGE: 20190315 4 1 doc1.xml FORM 4 X0306 4 2022-03-22 0 0001770787 10x Genomics, Inc. TXG 0001786391 Hindson Benjamin J. C/O 10X GENOMICS, INC. 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 1 1 0 0 See Remarks Class A Common Stock 2022-03-22 4 A 0 28476 0 A 188802 D Stock Option (Right to Buy) 69.56 2022-03-22 4 A 0 71189 0 A 2032-03-22 Class A Common Stock 71189 71189 D These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-sixteenth of the RSUs shall vest on May 21, 2022 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one forty-eighth of the shares on May 1, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. President and Chief Scientific Officer /s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson 2022-03-24